摘要
目的:测定鼻咽癌患者放射治疗前后可溶性白细胞介素-2受体水平。方法:测定了55例鼻咽癌患者血清可溶性白细胞介素-2受体(sIL-2R)水平治疗前后的变化并与35例健康成人对照。结果:鼻咽癌患者血清sIL-2R水平较正常对照明显升高,治疗后1个月、3个月及6个月逐渐下降,治疗后6个月血清sIL-2R水平回升预示肿瘤的复发转移。结论:提示sIL-2R可作为鼻咽癌临床诊断病情监测又一新的免疫生物学指标。
Soluble interleukin 2 receptor (sIL 2R) serum levels were measured in 55 patients with nasopharyngeal cancer and in 35 healthy individuals as control . The levels of sIL 2R elevated significantly before radiotherapy in the NPC group as compared with the control, and the levels gradually declined 1,3,6 months after irradiation. The re increase of sIL 2R 6 months after treatment predicted relapse or metastasis of NPC. The results suggest that sIL 2R can be used as a new marker of the immunobiological response of the host in monitoring the clinical course of NPC.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
1998年第10期751-753,共3页
Chinese Journal of Clinical Oncology
基金
省
部级科研基金
关键词
鼻咽癌
放射疗法
SIL-2R
Nasopharyngeal cancer Radiotherapy Soluble interleukin 2 receptor